RUXCOVID study (NCT04362137) ~ FAILED TO BENEFIT

[socrates_8]

Post by MPN-MATE Admin » Wed Dec 16, 2020 10:41 pm

Ruxolitinib fails to provide clinical benefit in patients with COVID-19-related cytokine storm

By Gizem Karakuleli Dec 15, 2020

Evening all...

Personally, I have found the commercial aspects of Big Pharma's race to earn the Prize, more than a tad disturbing...

This tale, is another of that ilk, where a little known rather expensive drug known as Ruxolitinib was Clinically Trialled to see how it might prevail or indeed overcome the cytokine storm, (and COVID-19 pneumonia), that sometimes ensues after a CV–19 infection...

While the final results are yet to be published, the News Headlines have already been leaked via the global media, and states as follows:

mpn-mate.com/forum/viewtopi...

Best of the season to all...

Steve

[Kdavie12]

Hope your mum is better and that you are also caring for yourself with your good diet and exercise.

[socrates_8 in reply to Kdavie12]

Hey Kdavie12...

Thanks for those well wishes...

She will have her procedure today & the doctor's all sounded very optimistic... So, fingers crossed...

I will reorganise myself, asap...

Cheers & best wishes to you & yours...

Steve

[Kdavie12 in reply to socrates_8]

Thinking of your mum.Best wishes and love to you and your mum.